Management of Symptomatic Arrhythmia

Immediate Assessment and Stabilization

The American Heart Association recommends immediate assessment of hemodynamic stability, followed by 12-lead ECG to distinguish between supraventricular and ventricular arrhythmias, with unstable patients requiring immediate cardioversion and stable patients requiring urgent cardiology evaluation to prevent sudden cardiac death 1, 2, 3
The American College of Cardiology suggests that hemodynamic stability must be assessed within seconds of patient contact, with continuous ECG monitoring and intravenous access mandatory for all patients presenting with any cardiac arrhythmia 4
The presence of near syncope indicates significant hemodynamic compromise and places the patient in a high-risk category requiring urgent intervention 1, 7

The American Heart Association recommends that patients demonstrating ongoing syncope or loss of consciousness, persistent hypotension despite position changes, acute heart failure symptoms, or ongoing chest pain suggesting ischemia are considered hemodynamically unstable and require immediate cardioversion 2, 3, 4, 8
For unstable supraventricular tachycardias, the American College of Cardiology suggests synchronized cardioversion should be performed at 50-100 J biphasic energy 3
For unstable ventricular arrhythmias, the American Heart Association recommends immediate cardioversion rather than attempting pharmacological termination 2, 3

The American Heart Association recommends obtaining a 12-lead ECG immediately to evaluate for QRS duration, regularity, pre-excitation patterns, AV dissociation or fusion complexes, and QT interval prolongation 1, 4, 9
The American College of Cardiology suggests that for narrow-complex regular tachycardia with near syncope, this likely represents AVNRT or AVRT, and elderly patients are particularly prone to syncope or near-syncope despite slower tachycardia rates compared to younger patients 1

The American College of Cardiology recommends vagal maneuvers as the first line of treatment for supraventricular tachycardia, followed by adenosine 6-12 mg IV rapid bolus if vagal maneuvers fail 4, 5, 6, 9
The American Heart Association suggests that for stable monomorphic ventricular tachycardia, amiodarone 150 mg IV over 10 minutes is the preferred agent 2, 3, 4, 6

The American Heart Association warns against using AV nodal blocking drugs for pre-excited atrial fibrillation or flutter, as this can accelerate the ventricular rate and cause hemodynamic collapse 4
The American College of Cardiology advises against giving serial AV nodal blocking agents with long half-lives, as profound bradycardia can develop from their overlapping effects 4

The American College of Cardiology recommends immediate cardiology or electrophysiology consultation, echocardiography, laboratory evaluation, and continuous cardiac monitoring with hospitalization for all patients with near syncope associated with arrhythmia 7, 9

The American Heart Association suggests that syncope or near-syncope with arrhythmia, structural or ischemic heart disease, abnormal ECG findings, and heart failure symptoms mandate hospital admission 2, 3, 7, 9, 11

The American College of Cardiology recommends catheter ablation as the definitive treatment for recurrent symptomatic SVT and considers it after the acute episode is managed 9, 10
The American Heart Association suggests that ICD implantation should be considered if ventricular arrhythmias are documented in patients with structural heart disease, particularly those with LVEF ≤35% 2, 3, 6